Posttranscriptional compensation for heterozygous disruption of the kidney-specific NaK2Cl cotransporter gene

Area of Science:

• Nephrology
• Molecular Biology
• Physiology

Background:

• The kidney-specific sodium-potassium-chloride cotransporter 2 (NKCC2) is crucial for kidney function.
• Loss-of-function mutations in NKCC2 are lethal in homozygous mice.
• The physiological impact of heterozygous NKCC2 deficiency is not well understood.

Purpose of the Study:

• To investigate the physiological consequences of reduced NKCC2 expression in heterozygous mice.
• To determine if partial NKCC2 deficiency affects blood pressure, fluid balance, or renal concentrating ability.
• To explore compensatory mechanisms in response to halved NKCC2 gene expression.

Main Methods:

• Comparative analysis of NKCC2 heterozygous (+/-) and wild-type (+/+) mice.
• Assessment of blood pressure, blood gases, electrolytes, and renal function parameters.
• In vitro microperfusion of isolated thick ascending limb (TAL) segments.
• Measurement of mRNA expression for key renal transporters.

Main Results:

• NKCC2 mRNA levels were approximately 55% lower in heterozygous mice, but protein levels remained near normal.
• No significant differences were observed in blood pressure, fluid balance, urine concentration/dilution, or furosemide response between genotypes.
• Despite ammonia challenge, plasma and urinary ammonia levels did not differ between NKCC2 +/+ and +/- mice.
• In vitro studies showed no difference in TAL NaCl reabsorption capacity between genotypes.

Conclusions:

• Halving NKCC2 gene expression does not impair blood pressure or fluid homeostasis in mice.
• Compensatory mechanisms, potentially involving increased protein trafficking to the luminal membrane, restore NKCC2 protein levels and function.
• These findings highlight the kidney's resilience and adaptive capacity in maintaining fluid and electrolyte balance.